# A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece

> **NCT04965870** · — · COMPLETED · sponsor: **Hellenic Study Group of Psychoneuroimmunology in Cancer** · enrollment: 200 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Trifluridine/Tipiracil

## Key facts

- **NCT ID:** NCT04965870
- **Lead sponsor:** Hellenic Study Group of Psychoneuroimmunology in Cancer
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-30
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-20
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04965870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04965870, "A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04965870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*